Stem Cell Factor Receptor (c-KIT) Codon 816 Mutations Predict Development of Bilateral Testicular Germ-Cell Tumors

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7674-7678

  Looijenga, Leendert H J ^a   De Leeuw, Hubert ^a   Van Oorschot, Monique ^a   Van Gurp, Ruud J H L M ^a   Stoop, Hans ^a   Gillis, Ad J M ^a   De Gouveia Brazao, Carlos A ^b   Weber, Rob F A ^b   Kirkels, Wim J ^b   Van Dijk, Thamar ^b   Von Lindern, Marieke ^b   Valk, Peter ^b   Lajos, Geczy ^c   Olah, Edit ^c   Nesland, Jahn M ^d   Fosså, Sophie D ^d   Oosterhuis, J Wolter ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CODON; CONTROLLED STUDY; GENE MUTATION; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; WILD TYPE;

ADULT; CODON; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; GERMINOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 10744221713     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mostofi, F. K., and Sesterhenn, I. A. Histological typing of testis tumours. Ed. 2, p. 132. Berlin: Springer, 1998.
2. Adami, H. O., Bergström, R., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Ziegler, H., Rahu, M., Gurevicius, R., and Stengrevics, A. Testicular cancer in nine northern European countries. Int. J. Cancer, 59: 33-38, 1994.
3. Skakkebæk, N. E., Holm, M., Hoei-Hansen, C., Jørgensen, N., and Rajpert-De Meyts, E. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. Apmis, 111: 1-11, 2003.
4. Skakkebæk, N. E. Possible carcinoma-in-situ of the testis. Lancet, 2: 516-517, 1972.
5. Møller, H. Decreased testicular cancer risk in men born in wartime. J. Natl. Cancer Inst. (Bethesda), 81: 1668-1669, 1989.
6. Jørgensen, N., Giwercman, A., Müller, J., and Skakkebæk, N. E. Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells. Histopathology, 22: 373-378, 1993.
7. Rajpert-De Meyts, E., and Skakkebæk, N. E. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J. Androl., 17: 85-92, 1994.
8. Looijenga, L. H. J., Stoop, H., De Leeuw, P. J. C., De Gouveia Brazao, C. A., Gillis, A. J. M., Van Roozendaal, K. E. P., Van Zoelen, E. J. J., Weber, R. F. A., Wolffenbuttel, K. P., Van Dekken, H., Honecker, F., Bokemeyer. C., Perlman, E. J., Schneider, D. T., Kononen, J., Sauter, G., and Oosterhuis, J. W. POU5FI (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res., 63: 2244-2250, 2003.
9. Holzbeierlein, J. M., Sogani, P. C., and Sheinfeld, J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering cancer center experience 1950 to 2001. J. Urol., 169: 2122-2125, 2003.
10. Lajos, G., Gomez, F., Mihaly, B., and Istvan, B. The incidence, prognosis, clinical and histological characteristics, treatment and outcome of patients with bilateral germ cell testicular cancer in Hungary. J. Cancer Res. Clin. Oncol., in press, 2003.
11. Dieckmann, K. P., and Loy, V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J. Clin. Oncol., 14: 3126-3132, 1996.
12. Heidenreich, A., and Moul, J. W. Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?. Semin. Urol. Oncol., 20: 234-238, 2002.
13. Giwercman, A., Müller, J., and Skakkebæk, N. E. Prevalence of carcinoma-in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J. Urol., 145: 77-80, 1991.
14. Berthelsen, J. G., Skakkebæk, N. E., von der Maase, H., Sorensen, B. L., and Mogensen, P. Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. Br. Med. J. (Clin. Res. Ed.), 285: 1683-1686, 1982.
15. Rorth, M., Rajpert-De Meyts, E., Andersson, L., Dieckmann, K. P., Fossa, S. D., Grigor, K. M., Hendry, W. F., Herr, H. W., Looijenga, L. H. J., Oosterhuis, J. W., et al. Carcinoma in situ of the testis. Scand. J. Urol, 205: 166-186, 2000.
16. Tian, Q., Frierson, H. F., Jr., Krystal, G. W., and Moskaluk, C. A. Activating c-kit gene mutations in human germ cell tumors. Am. J. Pathol., 154: 1643-1647, 1999.
17. Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M., Littlefield, J. W., Donovon, P. J., Blumenthal, P. D., Huggins, G. R., and Gearhart, J. D. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA, 95: 13726-13731, 1998.
18. Olie, R. A., Boersman, A. W. M., Dekker, M. C., Nooter, K., Looijenga, L. H. J., and Oosterhuis, J. W. Apoptosis of human seminoma cells upon disruption of their micro-environment. Br. J. Cancer, 73: 1031-1036, 1996.
19. Heinrich, M. C., Blanke, C. D., Druker, B. J., and Corless, C. L. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J. Clin. Oncol., 20: 1692-1703, 2002.
20. Colls, B. M., Harvey, V. J., Skelton, L., Thompson, P. I., and Frampton, C. M. Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994. J. Clin. Oncol., 14: 2061-2065, 1996.
21. Akre, O., Ekbom, A., Hsieh, C. C., Trichopoulos, D., and Adami, H. O. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J. Natl. Cancer Inst. (Bethesda), 88: 883-889, 1996.
22. Tatton, L., Morley, G. M., Chopra, R., and Khwaja, A. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem., 278: 4847-4853, 2003.